Literature DB >> 7595231

Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes.

B Verhoven1, R A Schlegel, P Williamson.   

Abstract

The appearance of phosphatidylserine (PS) on the cell surface during apoptosis in thymocytes and cytotoxic T lymphocyte cell lines provokes PS-dependent recognition by activated macrophages. Flow cytometric analysis of transbilayer lipid movements in T lymphocytes undergoing apoptosis reveals that downregulation of the adenosine triphosphate-dependent amino-phospholipid translocase and activation of a nonspecific lipid scramblase are responsible for PS reaching the surface from its intracellular location. Both mechanisms are expressed at the same time, and precede DNA degradation, zeiosis, and cell lysis in the apoptotic pathway.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7595231      PMCID: PMC2192221          DOI: 10.1084/jem.182.5.1597

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  31 in total

1.  A flow-cytometric method for the separation and quantitation of normal and apoptotic thymocytes.

Authors:  X M Sun; R T Snowden; D N Skilleter; D Dinsdale; M G Ormerod; G M Cohen
Journal:  Anal Biochem       Date:  1992-08-01       Impact factor: 3.365

2.  Phosphatidylserine vesicles inhibit phagocytosis of erythrocytes with a symmetric transbilayer distribution of phospholipids.

Authors:  D Pradhan; P Williamson; R A Schlegel
Journal:  Mol Membr Biol       Date:  1994 Jul-Sep       Impact factor: 2.857

3.  Do all programmed cell deaths occur via apoptosis?

Authors:  L M Schwartz; S W Smith; M E Jones; B A Osborne
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

Review 4.  Phagocyte recognition of cells undergoing apoptosis.

Authors:  J Savill; V Fadok; P Henson; C Haslett
Journal:  Immunol Today       Date:  1993-03

5.  Asymmetry in trans-bilayer lateral pressure may drive expansion of the secretion fusion pore.

Authors:  A Bogdanov; B Verhoven; R A Schlegel; P Williamson
Journal:  Biochem Soc Trans       Date:  1993-05       Impact factor: 5.407

Review 6.  Mechanism and function of changes in membrane-phospholipid asymmetry in platelets and erythrocytes.

Authors:  R F Zwaal; P Comfurius; E M Bevers
Journal:  Biochem Soc Trans       Date:  1993-05       Impact factor: 5.407

7.  Rapid loss and restoration of lipid asymmetry by different pathways in resealed erythrocyte ghosts.

Authors:  B Verhoven; R A Schlegel; P Williamson
Journal:  Biochim Biophys Acta       Date:  1992-02-17

8.  Ca2+ induces transbilayer redistribution of all major phospholipids in human erythrocytes.

Authors:  P Williamson; A Kulick; A Zachowski; R A Schlegel; P F Devaux
Journal:  Biochemistry       Date:  1992-07-14       Impact factor: 3.162

9.  Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages.

Authors:  V A Fadok; D R Voelker; P A Campbell; J J Cohen; D L Bratton; P M Henson
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

10.  Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells.

Authors:  V A Fadok; J S Savill; C Haslett; D L Bratton; D E Doherty; P A Campbell; P M Henson
Journal:  J Immunol       Date:  1992-12-15       Impact factor: 5.422

View more
  150 in total

Review 1.  Clearance: the last and often forgotten stage of apoptosis.

Authors:  V A Fadok
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

2.  Cardiolipin on the surface of apoptotic cells as a possible trigger for antiphospholipids antibodies.

Authors:  M Sorice; A Circella; R Misasi; V Pittoni; T Garofalo; A Cirelli; A Pavan; G M Pontieri; G Valesini
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

3.  Functional heterogeneity of anti-endothelial cell antibodies.

Authors:  A Bordron; R Révélen; F D'Arbonneau; M Dueymes; Y Renaudineau; C Jamin; P Youinou
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

4.  Specific binding of an antigen-antibody complex to apoptotic human neutrophils.

Authors:  Simon P Hart; Caroline Jackson; L Maximillian Kremmel; Mary S McNeill; Hubertus Jersmann; Karen M Alexander; James A Ross; Ian Dransfield
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

5.  Relationship between membrane permeability and specificity of human secretory phospholipase A(2) isoforms during cell death.

Authors:  Jennifer Nelson; Elizabeth Gibbons; Katalyn R Pickett; Michael Streeter; Ashley O Warcup; Celestine H-Y Yeung; Allan M Judd; John D Bell
Journal:  Biochim Biophys Acta       Date:  2011-04-12

6.  Nanoelectropulse-induced phosphatidylserine translocation.

Authors:  P Thomas Vernier; Yinghua Sun; Laura Marcu; Cheryl M Craft; Martin A Gundersen
Journal:  Biophys J       Date:  2004-06       Impact factor: 4.033

7.  Macrophage surface expression of annexins I and II in the phagocytosis of apoptotic lymphocytes.

Authors:  Xiaoxuan Fan; Stephen Krahling; Douglas Smith; Patrick Williamson; Robert A Schlegel
Journal:  Mol Biol Cell       Date:  2004-04-02       Impact factor: 4.138

8.  Bystander killing during avian leukosis virus subgroup B infection requires TVB(S3) signaling.

Authors:  Felipe Diaz-Griffero; Steven A Hoschander; Jürgen Brojatsch
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

Review 9.  TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity.

Authors:  Gordon J Freeman; Jose M Casasnovas; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

10.  In vivo dynamic imaging of myocardial cell death using 99mTc-labeled C2A domain of synaptotagmin I in a rat model of ischemia and reperfusion.

Authors:  Zhonglin Liu; Ming Zhao; Xiaoguang Zhu; Lars R Furenlid; Yi-Chun Chen; Harrison H Barrett
Journal:  Nucl Med Biol       Date:  2007-09-19       Impact factor: 2.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.